FDA label
What is naproxen used for?
The FDA-approved uses of naproxen, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Naproxen Tablets are indicated for: the relief of the signs and symptoms of: rheumatoid arthritis; osteoarthritis; ankylosing spondylitis; polyarticular juvenile idiopathic arthritis; tendonitis; bursitis; acute gout; pain; primary dysmenorrhea.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted naproxen?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Naproxen, tablet
Indications and Usage, quoted from the label by ScieGen Pharmaceuticals, Inc. (ANDA212517). Cross-references to other label sections are left out.
Naproxen Tablets are indicated for: the relief of the signs and symptoms of:
- rheumatoid arthritis
- osteoarthritis
- ankylosing spondylitis
- polyarticular juvenile idiopathic arthritis
- tendonitis
- bursitis
- acute gout
the management of:
- pain
- primary dysmenorrhea
Source: DailyMed label, set id 81e22c1f-f94d-46e9-8b7d-72dc2518319e, version 9, effective March 18, 2026. NDC 50228-434, one of 156 listings for this product.
Naproxen Sodium, tablet
Indications and Usage, quoted from the label by Granules India Ltd (ANDA074140). Cross-references to other label sections are left out.
Naproxen tablets are indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • Polyarticular Juvenile Idiopathic Arthritis
Naproxen tablets is also indicated for: the relief of signs and symptoms of:
- tendonitis • bursitis • acute gout the management of: • pain • primary dysmenorrhea
Source: DailyMed label, set id 1f8da545-bcfe-4c22-a9f1-d34108120aa0, version 9, effective October 7, 2026. NDC 62207-745, one of 23 listings for this product.
Naproxen, tablet, delayed release
Indications and Usage, quoted from the label by TruPharma LLC (ANDA216908). Cross-references to other label sections are left out.
Naproxen delayed-release tablets are indicated for:
The relief of the signs and symptoms of:
- rheumatoid arthritis
- osteoarthritis
- ankylosing spondylitis
- polyarticular juvenile idiopathic arthritis
Source: DailyMed label, set id 004bb832-29d5-add0-e063-6394a90a90f4, version 5, effective October 1, 2026. NDC 52817-380, one of 13 listings for this product.
Questions
What is naproxen used for?
The FDA label says: “Naproxen Tablets are indicated for: the relief of the signs and symptoms of: rheumatoid arthritis; osteoarthritis; ankylosing spondylitis; polyarticular juvenile idiopathic arthritis; tendonitis; bursitis; acute gout; pain; primary dysmenorrhea.”
What drug class is naproxen?
FDA lists naproxen in the Nonsteroidal Anti-inflammatory Drug established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Naproxen
- Is Naproxen a controlled substance?Federal schedule
- Generic for NaprosynFDA Orange Book
- Generic for Ec-naprosynFDA Orange Book
- Generic for NaprelanFDA Orange Book
- Generic for AnaproxFDA Orange Book
- Generic for Anaprox DSFDA Orange Book
- Nonsteroidal Anti-inflammatory Drugs listFDA drug class
- NDC 24979-249Naproxen NDC record
- NDC 24979-250Naproxen NDC record
- NDC 24979-251Naproxen NDC record